Generics and Biosimilars Asia 2011

According to companiesandmarkets.com, the global generics market is forecast to be valued at $183.2 billion by 2014 and Asia Pacific will account for 36.2% of the global generics market. With an impressive CAGR of 12.9% through 2009-2012 and annual returns of US $200 billion from patents expiring in the next five years, the generics industry is looking at the next wave of evolution as big pharmaceutical companies start eyeing a bigger share of the generic drugs market.

With strong demand for affordable healthcare throughout Asia governments are favoring the production and prescription of generics and biosimilars. The Generics & Biosimilars Asia 2011 conference is set to address many of the pressing issues faced by both innovator and generic drug companies. Attendees will be able to network, discuss and learn from peers facing similar challenges in market access, pricing and the evolving pharmaceutical industry.